Roger Kuan, partner and chair of Haynes and Boone, LLP’s Precision Medicine and Digital Health Practice (PMDH) group, is the contributing editor to the International Comparative Legal Guides (ICLG) “Digital Health 2021” treatise.
Published by the Global Legal Group, the second edition of the treatise covers global laws and regulations relating to digital health and healthcare IT data use, data sharing, intellectual property, commercial agreements, artificial intelligence (AI), and machine learning and liability.
Kuan and David Wallace of Johnson & Johnson co-wrote an introduction to the recently published book, which highlights how digital technologies have transformed healthcare from a provider-centric, “one size fits all” practice to a personalized and patient-centric model.
Kuan also co-wrote a chapter surveying legal developments in the U.S digital health sector with Haynes and Boone Partners Jason Novak, a member of the PMDH group, and Phil Kim in the firm’s Healthcare Transactions and Regulatory group.
Novak co-authored a separate chapter with Irina Ridley of NeuroPace, Inc., analyzing key considerations for using data in the digital health sector. The lawyers explain that the proper generation, acquisition, maintenance, and use of data is essential to a successful digital health endeavor.
Digital Health 2021 is intended to be a one-stop reference guide for digital health companies seeking a high-level overview of legal and regulatory issues in various geographic jurisdictions around the world. The book contains analysis from other leading lawyers in the digital health sector, including René Quashie of the Consumer Technology Association, who wrote on an introductory chapter about the trustworthiness of AI in healthcare.
To read the guide, click here.
“Our lawyers closely follow the latest trends and legal developments in the digital health sphere, and we are thrilled to lend our insights to this comprehensive guide,” Kuan said.
Haynes and Boone’s Precision Medicine and Digital Health Practice Group provides full-service counsel to the key players in precision medicine and digital health – from technology startups to established corporations, non-profit research institutions, universities, hospital systems, pharmaceuticals, and investors supporting the industry. Lawyers on the team draw on the firm’s highly regarded healthcare, life sciences, technology and IP experience to address trends in evolving markets, cutting-edge advances in technology, and legal and regulatory changes.
Haynes and Boone is an international corporate law firm with offices in Texas, New York, California, Charlotte, Chicago, Denver, Washington, D.C., London, Mexico City and Shanghai, providing a full spectrum of legal services in energy, technology, financial services and private equity. With 600 lawyers, Haynes and Boone is ranked among the largest U.S.-based firms by The National Law Journal, The American Lawyer and The Lawyer. It also was recognized across the board for excellence in the BTI Consulting Group’s 2020 “A-Team” report, which identifies the law firms that in-house counsel commend for providing superior client service.